Melodi is developing a clinically proven technology designed to reduce surgical complications in breast reconstruction procedures. This solution addresses the high rates of complications and re-operations faced by women undergoing reconstruction after mastectomy.
Funding
$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Breast reconstruction after mastectomy often leads to high rates of complications, including infection and the need for re-operation, impacting patient outcomes and increasing healthcare costs. Current reconstructive techniques may not adequately support tissue integration and long-term stability.
Solution
Melodi Health is developing the Melodi Matrix, a clinically evaluated technology designed to reduce surgical complications in breast reconstruction procedures. The matrix aims to improve tissue integration and provide structural support during the reconstruction process, potentially lowering the risk of infection and the need for subsequent surgeries. By enhancing the body's natural healing response, the Melodi Matrix seeks to improve long-term outcomes and patient satisfaction following breast reconstruction. The device is currently undergoing clinical trials to assess its safety and efficacy in women undergoing reconstruction after mastectomy.
Target Audience
The primary target audience includes breast reconstruction surgeons and women undergoing mastectomy who are choosing to have reconstructive surgery.
Features
- Biocompatible matrix designed to support tissue regeneration and integration.
- Aims to reduce complications such as infection, seroma formation, and capsular contracture.
- Provides structural support to the reconstructed breast, potentially improving aesthetic outcomes.
- Designed for use in immediate or delayed breast reconstruction procedures.
- Undergoing clinical trials to evaluate safety and effectiveness.